Ampelopsin induces MDA-MB-231 cell cycle arrest through cyclin B1-mediated PI3K/AKT/mTOR pathway in vitro and in vivo

Data publikacji: 24 sty 2023

Zakres stron: 75 - 90

Przyjęty: 31 lip 2022

DOI: https://doi.org/10.2478/acph-2023-0005

Słowa kluczowe

PI3K/AKT/mTOR pathway, cyclin B1, breast cancer, cell cycle arrest, ampelopsin

© 2023 Minjun Meng et al., published by Sciendo

This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.